The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease
Jamadar A, Suma SM, Mathew S, Fields TA, Wallace DP, Calvet JP, Rao R. (2021). The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease. Cell Death Dis. 2021 Oct 14;12(10):947. PMID: 34650051 [Article]